Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 2/20 | 1.00 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 1.00 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 5/20 | 0.75 |
| ▸ | LMNA | P02545 | 3/20 | 0.75 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.75 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.75 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.59 |
| ▸ | PPARG | P37231 | 6/20 | 0.57 |
| ▸ | PPARD | Q03181 | 6/20 | 0.57 |
| ▸ | PPARA | Q07869 | 6/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1700807 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| Sebacic Acid SCHEMBL17889405 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| Adipic Acid SCHEMBL1149291 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8984594 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| Sebacic Acid SCHEMBL6060953 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL150421 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL28484 | 1.00 | — | — | |
| 1,5-Pentanediol SCHEMBL20696141 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL21114450 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL3503243 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4CAMK2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 358 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027162-A1 | MUCISPIRILLUM COMPOSITIONS AND CANCER TREATMENT METHODS THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-01-29 | — | — | US | claimed |
| EP-4555326-A2 | MUCISPIRILLUM COMPOSITIONS AND CANCER TREATMENT METHODS THEREOF | President And Fellows Of Harvard College (US) | 2025-05-21 | — | — | EP | claimed |
| CN-119894525-A | Mucispirillum compositions and methods of treating cancer | 哈佛大学校长及研究员协会 | 2025-04-25 | — | — | CN | claimed |
| CN-119185405-B | Gaultheria tenuifolia volatile oil and application thereof | 山东大学 | 2025-02-28 | — | — | CN | claimed |
| CN-119286415-A | Self-adhesive asphalt waterproof coiled material for passive room | 河北宇阳泽丽防水材料有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119185405-A | Gaultheria tenuifolia volatile oil and application thereof | 山东大学 | 2024-12-27 | — | — | CN | claimed |
| CN-116024027-B | Grease composition with anti-swing abrasion performance and preparation method thereof | 中国石油化工股份有限公司 | 2024-09-20 | — | — | CN | claimed |
| WO-2024015955-A2 | MUCISPIRILLUM COMPOSITIONS AND CANCER TREATMENT METHODS THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-01-18 | — | — | WO | claimed |
| CN-116463159-A | Antioxidant additive, preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-116024027-A | Grease composition with anti-swing abrasion performance and preparation method thereof | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-101341161-A | Bis-platinum complexes with antitumor activity | CELL THERAPEUTICS EUROPE SRL (IT) | 2009-01-07 | — | — | CN | claimed |
| EP-1968991-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | Sede Secondaria Della Cell Therapeutics, Inc. (IT) | 2008-09-17 | — | — | EP | claimed |
| WO-2008098776-A1 | TUBULAR SUPPORTING PROSTHESIS CAPABLE OF GROWING | Universität Zürich (CH) | 2008-08-21 | — | — | WO | claimed |
| WO-2007071415-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | CELL THERAPEUTICS, INC. - SEDE SECONDARIA (IT) | 2007-06-28 | — | — | WO | claimed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| EP-0802254-B1 | Refrigerator oil composition | IDEMITSU KOSAN CO (JP) | 2003-07-09 | — | — | EP | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| US-6008169-A | Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof | IDEMITSU KOSAN CO., LTD. (JP) | 1999-12-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027162-A1 | MUCISPIRILLUM COMPOSITIONS AND CANCER TREATMENT METHODS THEREOF | SAAL1, CD74, MUC1 | GPR84 104/4885FFAR1 1128/4885FFAR4 2764/4885 |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | GPR84 520/4885FFAR1 88/4885FFAR4 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.